Evidence map›Paper›PMID 26404387›Full record

ReviewBiomolecules2015

Arsenic Disruption of DNA Damage Responses-Potential Role in Carcinogenesis and Chemotherapy.

Clarisse S Muenyi, Mats Ljungman, J Christopher States

Open access · goldAbstract readReview
In one paragraph

Review in Biomolecules, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 86 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Memory effects of prior subculture may impact the quality of multiomic perturbation profiles.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  8. Article
  9. Update of the risk assessment of inorganic arsenic in food.EFSA journal. European Food Safety Authority · 2024
    Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Impacts of arsenic on Rad18 and translesion synthesis.Toxicology and applied pharmacology · 2022
    Article
  16. Unboxing the molecular modalities of mutagens in cancer.Environmental science and pollution research international · 2022
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Clarisse S MuenyiDepartment of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY 40292, USA. clarisse.muenyi@louisville.edu.
Mats LjungmanDepartments of Radiation Oncology and Environmental Health Sciences, University of Michigan, Ann Arbor, MI 48109-2800, USA. ljungman@med.umich.edu.
J Christopher StatesDepartment of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY 40292, USA. jcstates@lousiville.edu.
University of Louisville · USUniversity of Michigan–Ann Arbor · US

Funding

Strategic Vision & Impact on Environmental HealthP30ES017885 · NIEHS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Dana Dolinoy · 2011 to 2026
$21.3M
Arsenic Induced Miotic Arrest Associated ApoptosisR01ES011314 · NIEHS · UNIVERSITY OF LOUISVILLE · PI STATES, J CHRISTOPHER · 2003 to 2009
$1.4M
Development and Validation of BruChase-Seq and BrUV-SeqR01HG006786 · NHGRI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LJUNGMAN, MATS · 2012 to 2014
$1.1M
Mechanisms of Genotoxic Stress-regulated Gene Expression in Human CellsR21ES020946 · NIEHS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LJUNGMAN, MATS · 2012 to 2013
$424k
Differential miRNA expression & progression of arsenic induced skin cancersR21ES023627 · NIEHS · UNIVERSITY OF LOUISVILLE · PI STATES, J CHRISTOPHER · 2015 to 2016
$422k
NHGRI NIH HHS R01 HG006786NHGRI NIH HHS R01HG006786NIEHS NIH HHS P30 ES017885NIEHS NIH HHS P30ES017885NIEHS NIH HHS R01 ES011314NIEHS NIH HHS R01ES011314NIEHS NIH HHS R21 ES020946NIEHS NIH HHS R21ES020946NIEHS NIH HHS R21 ES023627NIEHS NIH HHS R21ES023627
6 · The paper itself

Abstract

Arsenic is a Class I human carcinogen and is widespread in the environment. Chronic arsenic exposure causes cancer in skin, lung and bladder, as well as in other organs. Paradoxically, arsenic also is a potent chemotherapeutic against acute promyelocytic leukemia and can potentiate the cytotoxic effects of DNA damaging chemotherapeutics, such as cisplatin, in vitro. Arsenic has long been implicated in DNA repair inhibition, cell cycle disruption, and ubiquitination dysregulation, all negatively impacting the DNA damage response and potentially contributing to both the carcinogenic and chemotherapeutic potential of arsenic. Recent studies have provided mechanistic insights into how arsenic interferes with these processes including disruption of zinc fingers and suppression of gene expression. This review discusses these effects of arsenic with a view toward understanding the impact on the DNA damage response.

Indexed as

AnimalsArsenicCarcinogenesisCell CycleDNA DamageDNA RepairHumansUbiquitinationArsenicarsenicDNA damage responseDNA repairMSH2ubiquitinationXPC

Identifiers

PMID26404387
PMCPMC4693233
OpenAlexW2145873182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.